Katie Coleman: My proudest moment of 2024
Katie Coleman, Product and Engineering Lead at the Rare Cancer Research Foundation, shared a post on X:
“After a mountain of advice that books on illness don’t sell, this might be my proudest moment of 2024.
PS – Everyone who has sent photos from Barnes and Noble, bookstores and libraries across the country – THANK YOU!
Makes my day every time.”
Katie Coleman, Product and Engineering Lead at the Rare Cancer Research Foundation and President of the Chromophobe and Oncocytic Tumor Alliance (COA), is a dedicated software engineer with a mission for creating intuitive, user-friendly products.
As a rare kidney cancer survivor, she is deeply committed to medical research and advocacy. Her personal experience helps her to promote collaborations that advance rare cancer research. Katie combines her technical expertise and unique perspective to develop products that improve patient outcomes and support the foundation’s mission.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023